
浏览全部资源
扫码关注微信
1.400016 重庆,重庆医科大学 第一临床学院
2.400016 重庆,重庆医科大学 附属第一医院检验科
[ 张莉萍,E-mail:Liuzhangcq@yahoo.com ZHANG Liping, E-mail:Liuzhangcq@yahoo.com
收稿:2018-04-18,
修回:2018-06-28,
纸质出版:2018-10-15
移动端阅览
田小浪, 贾晓炯, 张莉萍. 广泛耐药肺炎克雷伯菌感染的流行病学调查和危险因素分析[J]. 第三军医大学学报, 2018,40(19):1810-1814.
Xiaolang TIAN, Xiaojiong JIA, Liping ZHANG. Epidemiological survey and risk factor analysis of extensively drug-resistant
田小浪, 贾晓炯, 张莉萍. 广泛耐药肺炎克雷伯菌感染的流行病学调查和危险因素分析[J]. 第三军医大学学报, 2018,40(19):1810-1814. DOI: 10.16016/j.1000-5404.201804128.
Xiaolang TIAN, Xiaojiong JIA, Liping ZHANG. Epidemiological survey and risk factor analysis of extensively drug-resistant
目的
2
分析广泛耐药肺炎克雷伯菌(extensively drug-resistant
Klebsiella pneumoniae
XDR-KP)的分子流行病学特点及感染危险因素。
方法
2
收集2012年1月至2015年12月重庆医科大学附属第一医院临床标本中分离的39株XDR-KP菌株作为病例组,同时按1 :2的比例配对随机选择78例同期非XDR-KP菌株作为对照组,采用卡方检验和Logistic回归模型对患者病例资料进行相关危险因素分析,并采用脉冲场凝胶电泳(PFGE)进行分子流行病学分析。
结果
2
多因素Logistic回归分析显示,入住ICU(
OR
:3.01
95%
CI
: 1.12-8.07
P
=0.029)、内置引流管(
OR
:3.24
95%
CI
:1.11-9.45
P
=0.032)和碳青霉烯类抗生素使用(
OR
:5.08
95%
CI
:1.42-18.16
P
=0.012)是导致XDR-KP感染的独立危险因素;PFGE结果显示,39株广泛耐药肺炎克雷伯菌可分为35个克隆型别,其中有4个克隆型别分别由2株紧密相关的菌株组成,但均来自不同科室,提示实验菌株不存在各科室间的克隆传播现象。
结论
2
XDR-KP感染形势严峻,加强ICU病房的监管和防控,减少相关侵入性操作及合理使用碳青霉烯类抗生素是防止广泛耐药菌株的产生与流行的有效措施。
Objective
2
To analyze the epidemiological characteristics and risk factors of extensively drug-resistant
Klebsiella pneumoniae
(XDR-KP) infections.
Methods
2
A total of 39 strains of XDR-KP isolated from our hospital during January 2012 and December 2015 were collected and assigned into the disease group. And another 78 strains (at a ratio of 1:2) of non-XDR-KP bacteria randomly collected in same duration were assigned into the control group.
Chi
-square test and logistic regression analysis were performed to evaluate the related risk f
actors. And the molecular epidemiology was characterized by pulsed-field gel electrophoresis (PFGE).
Results
2
Multivariate logistic regression analysis showed that ICU admission (
OR
=3.01
95%
CI
: 1.12~8.07
P
=0.029)
drainage tube (
OR
=3.24
95%
CI
: 1.11~9.45
P
=0.032) and carbapenems exposure (
OR
=5.08
95%
CI
: 1.42~18.16
P
=0.012) were the independent risk factors of XDR-KP infection. PFGE results showed that the 39 strains of XDR-KP were divided into 35 clone types. Moreover
4 clone types were composed of 2 closely related strains
but these strains were collected from different wards
indicating that no transmitting phenomenon was observed among the investigated isolates among different wards.
Conclusion
2
The situation of XDR-KP infection is fairly severe. Strengthening the supervision and control of ICU wards
fewer invasive operations and reasonable use of carbapenem antibiotics would be necessary to prevent the occurrence and prevalence of XDR-KP.
TUMBARELLO M, TRECARICHI E M, DE ROSA F G, et al . Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study[J ] . J Antimicrob Chemother, 2015, 70(7):2133-2143. DOI:10.1093/jac/dkv086.
DASS R, DEKA N M, BARMAN H, et al . Empyema thoracis: analysis of 150 cases from a tertiary care centre in North East India[J ] . Indian J Pediatr, 2011, 78(11): 1371-1377. DOI:10.1007/s12098-011-0416-y.
SCHWABER M J, LEV B, ISRAELI A, et al . Containment of a country-wide o utbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention[J ] . Clin Infect Dis, 2011, 52(7):848-855. DOI:10.1093/cid/cir025.
SBRANA F, MALACARNE P, BASSETTI M, et al . Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization[J ] . Minerva Anestesiol, 2016, 82(6):635-640.
胡付品, 朱德妹, 汪复, 等. 2015年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志, 2016, 16(6):685-694.
DOI:10.16718/j.1009-7708.2016.06.003. HU F P, ZHU D M, WANG F, et al . Report of CHINET antimicrobial resistance surveillance program in 2015[J ] . Chin J Infect Chemother, 2016, 16(6):685-694. DOI:10.16718/j.1009-7708.2016.06.003.
MAGIORAKOS A P, SRINIVASAN A, CAREY R B, et al . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J ] . Clin Microbiol Infect, 2012, 18(3): 268-281. DOI:10.1111/j.1469-0691.2011.03570.x.
SADER H S, FARRELL D J, JONES R N. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers(2005- 2009)[J]. Diagn Microbiol Infect Dis, 2011, 69(2): 223-227. DOI:10.1016/j.diagmicrobio.2010.10.020.
FRAENKEL-WANDEL Y, RAVEH-BRAWER D, WIENER-WELL Y, et al . Mortality due to blaKPC Klebsiella pneumonia bacteraemia[J ] .J Antimicrob Chemother, 2016, 71(4):1083-1087.DOI:10.1093/jac/dkv414.
SCHWABER M J, CARMELI Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae[J]. Clin Infect Dis, 2014, 58(5):697-703. DOI:10.1093/cid/cit795.
VAN DUIN D, DOIY. Outbreak of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae: are we at the end of the road? [J]. J Clin Microbiol, 2015, 53(10):3116-3117. DOI:10.1128/JCM.01399-15.
CHIA J H, SU L H, LEE M H, et al . Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure[J ] .Microb Drug Resist, 2010, 16(4): 317-325. DOI:10.1089/mdr.2009.0048.
BORER A, SAIDEL-ODES L, ESKIRA S, et al . Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospita l patients initially only colonized with carbapenem-resistant K pneumoniae[J ] . Am J Infect Control, 2012, 40(5): 421-425. DOI:10.1016/j.ajic.2011.05.022.
HUSSEIN K, RAZ-PASTEUR A, FINKELSTEIN R, et al . Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae[J ] . J Hosp Infect, 2013, 83(4): 307-313. DOI:10.1016/j.jhin.2012.10.012.
WU D, CAI J, LIU J. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae[J]. South Med J, 2011, 104(2): 106-110. DOI:10.1097/SMJ.0b013e318206063d.
SCHECHNER V, KOTLOVSKY T, KAZMA M, et al . Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected[J ] . Clin Microbiol Infect, 2013, 19(5): 451-456. DOI:10.1111/j.1469-0691.2012.03888.x.
GÓMEZ RUEDA V, ZULETA TOBóN J J. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case control study[J]. Colomb Med(Cali), 2014, 45(2): 54-60.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621